Human study · Supplements / medicine · 15 Sept 2026
Framingham data suggest menopause timing is not what first raises women’s pulse pressure
Source: News-Medical
What the research found
Study (observational, Framingham Heart Study). Habib, Gary F. Mitchell and colleagues report in Hypertension (doi 10.1161/HYPERTENSIONAHA.126.27015) on 6,760 unique participants across three visits spanning 14 years. Pulse pressure reached a nadir and flipped from falling to rising about a decade earlier in women (late 30s; modeled nadirs ~37–39) than in men (late 40s; ~47). Early, typical, or late menopause had no influence on when women’s pulse pressure bottomed, and postmenopausal nadirs sat an average of 6, 14, and 19 years before the final menstrual period. After age 60, mean pulse pressure was higher in women than in men. Association is not a reason to start, stop, or change blood-pressure medicine. Educational vascular-aging notes, not a diagnosis.
Evidence level: Human study. A study in people, but an association isn't proof of cause.
More supplements / medicine news
- In mice, the experimental drug KCL-286 reduced DNA breaks and brain inflammation in an Alzheimer's model
- In aged rats, two weeks of the experimental drug cinaciguat cut circulating amyloid-beta about in half and brought LDL down to youthful levels
- In 104 people with a sudden retinal-artery blockage, papaverine use lined up with better functional vision in a retrospective comparison
- A Cell Metabolism letter questions whether a fasting GLP-1 level shows how many gut L-cells a person has
- In FDA reports, caffeine and stimulant supplement use was tied to cardiac arrest about 11 times more often, and 45 percent of those cardiovascular reports were ages 18 to 34